Publications
MicroRNA as key players in skin regeneration and anti-aging pathways
October 12, 2026
This review highlights current knowledge of miRNA-mediated regulation in skin regeneration and aging and synthesizes recent findings on their individual functions in these biological processes.
Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies
August 7, 2026
This review advances the hypothesis that benzodiazepines should be preferentially substituted by alternative sedative strategies in septic shock and critical illness, and that ACBP/DBI is a mechanistically grounded biomarker and therapeutic target linking sedation biology, immune dysfunction and accelerated aging.
Triptolide inhibits ovarian cancer growth and metastasis via reprogramming of tumor-associated macrophages
July 7, 2026
Our findings indicate that the suppression of ovarian cancer by Triptolide is mediated in part through its capacity to reprogram TAMs via the Nrf2 pathway.
The IRE1α-XBP1s-NFκB axis controls cell survival and epithelial differentiation under osmotic stress through arachidonic acid metabolism activation
April 27, 2026
Our findings highlight a central role for the IRE-XBP1s-NFB signaling axis in coordinating cell stress responses and epithelial differentiation through AA metabolism activation.
Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential
March 9, 2026
This review meticulously dissects CNPY2’s structural characteristics, expression patterns, and biological functions across various disorders, emphasizing its role on tumor initiation, microenvironmental stress, and chemoresistance, and evaluating its potential as a therapeutic target.
Antifungal peptides: from modes of action to synergistic and immunologic potential
January 30, 2026
This review underscores the potential of AFPs as viable candidates for the development of next-generation antifungal therapies, advocating their multimodal advantage that spans beyond standalone activity, including their synergistic and immune-regulatory potential.
Reversal of Cushing syndrome by antibody-mediated neutralization of ACBP/DBI
January 26, 2026
This study investigates the therapeutic potential of ACBP/DBI neutralization in a well-established murine model of CS, positioning ACBP/DBI neutralization as a viable therapeutic strategy for established CS.
Burning fat with cysteine depletion
November 13, 2025
This News & Thouhgts article comments on two complementary articles by Varghese et al and Lee et al showing that cysteine depletion through combined dietary and genetic means in mice evokes a unique stress response in the liver to amplify these metabolic outcomes and offer a potentially new treatment option for obesity.